Hi ,

• This Startup Is Rewriting The Language Of Life To Make Smart Biologics. The development of smart biologics has been stuck in the same paradigm—until now. A new startup Pearl Bio is rewriting the language of life with its genetically recoded organism. (Forbes)

Pearl Bio co-founders: Michael Jewett, Amy Cayne Schwartz, and Farren Isaacs.

• How Do We Unite Synbio and Pharma? Insights from SynBioBeta 2023. The synbio community often talks about the industry’s lofty promises to solve many of the world’s biggest problems. And we should talk about that. The youthful willingness to take big risks and chase moonshots is a wonderful and unique characteristic of our community.

• Synthetic biology startup Ardra is brewing up big plans with its fermentation technology. Despite a tough investment climate and a series of setbacks, Ardra is facing down the challenges of precision fermentation. (Betakit)

• bit.bio is industrializing human cell manufacturing: bit.bio has reached a new level of precision and consistency of their induced pluripotent stem cells (iPSC)-derived cell products. (bit.bio)

• Upside Foods secures USDA approval for its cultivated meat: Several companies are seeking approval from U.S. regulators for cultivated meat and fish products. On June 8, California-based Good Meat became the first company to receive USDA label approval. (Reuters)

• Capra Biosciences is reducing carbon waste in chemicals: With the help of the Prince William County Science Accelerator, two founders are changing how we get the chemicals and products we use daily. (Technical.ly DC)

A note from our sponsor: Mayfield is an early-stage venture capital firm with a people-first philosophy and $3 billion under management. The Firm has a proven track record of partnering with founders starting at the inception stage to help build iconic enterprise, AI-first, deeptech, and human and planetary health companies. The Firm has invested in more than 550 companies, resulting in 120 IPOs and more than 225 acquisitions.

Other news:

• Pioneering Synthetic Biology Workflows: Biosyntia Adopts Sphere Fluidics' Pico-Mine Platform.

• Novel Biopolymers: Creating a Fully Programmable Protein-Translation System.  

• DNA Folding Technique Opens Array of Possibilities for Molecular Biology & Nanotech

• CRISPR Rice Created That is Resistant to Multiple Diseases

• Nanopore-Nanobody Interaction Could Be Key to Rapid, Accurate Disease Diagnostics

• The Journey Toward an Artificial Kidney is a 'Whale' of a Tale

• F3 launches new aquafeed challenge to identify top krill replacements. Enter your krill replacement product before August 31, 2023, to join the race to replace krill in aquaculture feeds. (F3)

• Synthetic human embryos created in groundbreaking advance. Scientists say these model embryos could provide a crucial window on the impact of genetic disorders and the biological causes of recurrent miscarriage. (The Guardian)

• HexisLab, a UK-based biotech startup secures £490K to pioneer sustainable beauty revolution. Armed with proprietary AI technology, HexisLab aims to revolutionize the beauty, skincare, personal care, nutraceuticals, and pharmaceutical industries by creating eco-friendly, safe, and natural products. (Tech Funding News)

• Precision fermentation: When does it make commercial sense? AgFunder News (AFN) caught up with Dr. Casey Lippmeier, SVP innovation at precision fermentation specialist Conagen at the recent SynBioBeta conference (AgFunder News)

Regards,
Jeff

---

Jeff Buguliskis, PhD 

Director of Content, SynBioBeta

Who's hiring?

• Ginkgo Bioworks

• BioMADE

• NSCEB

• Inscripta

• Twist Bioscience

• LanzaTech

• Latch Bio

• Solugen

• bit.bio

• Read more at https://www.synbiobeta.com/jobs